Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Le Conte

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The American Review of Respiratory Disease|May 1, 1993
Lung distribution and pharmacokinetics of aerosolized tobramycinP Le Conte, G Potel, P Peltier, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 9, 2016
Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case-control studyD Lepelletier, V Pinaud, P Le Conte, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 5, 2016
Peritonsillar abscess (PTA): clinical characteristics, microbiology, drug exposures and outcomes of a large multicenter cohort survey of 412 patients hospitalized in 13 French university hospitalsD Lepelletier, V Pinaud, P Le Conte, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1991
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlationG Potel, J Caillon, B Fantin, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1997
Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivoD Bugnon, G Potel, Y Q Xiong, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1995
Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or bothY Q Xiong, J Caillon, X Y Zhou, et al.
Resuscitation|March 17, 2018
Prognostic performance of early absence of pupillary light reaction after recovery of out of hospital cardiac arrestF Javaudin, B Leclere, J Segard, et al.
Annals of Intensive Care|March 6, 2026
Guidelines for the Initial Assessment of Respiratory Distress in the Emergency DepartmentP Le Borgne, A W Thille, J Guenezan, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The American Review of Respiratory Disease|May 1, 1993
Lung distribution and pharmacokinetics of aerosolized tobramycinP Le Conte, G Potel, P Peltier, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 9, 2016
Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case-control studyD Lepelletier, V Pinaud, P Le Conte, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 5, 2016
Peritonsillar abscess (PTA): clinical characteristics, microbiology, drug exposures and outcomes of a large multicenter cohort survey of 412 patients hospitalized in 13 French university hospitalsD Lepelletier, V Pinaud, P Le Conte, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1991
Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlationG Potel, J Caillon, B Fantin, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1997
Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivoD Bugnon, G Potel, Y Q Xiong, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1995
Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or bothY Q Xiong, J Caillon, X Y Zhou, et al.
Resuscitation|March 17, 2018
Prognostic performance of early absence of pupillary light reaction after recovery of out of hospital cardiac arrestF Javaudin, B Leclere, J Segard, et al.
Annals of Intensive Care|March 6, 2026
Guidelines for the Initial Assessment of Respiratory Distress in the Emergency DepartmentP Le Borgne, A W Thille, J Guenezan, et al.
Pageof 3